Mol Neurobiol 61(10):83448360 Gross EC, Lisicki M, Fischer D, Sndor PS, Schoenen J (2019) The metabolic face of migraine - from pathophysiology to treatment
Competitive Pressure Pharmaceutical competitors will likely accelerate their own triple-agonist pipelines
We urge consumers to exercise extreme caution when buying medicines and medical devices online, including through social media and other digital platforms, the TGA said
Umpierrez G, Tof Povedano S, Prez Manghi F, Shurzinske L, Pechtner V
Der Spiegel
Compared to dulaglutide, tirzepatide at both 5 and 10 mg doses has shown improved glycemic control as well as weight management with similar levels of tolerability